Rh-negative blood is strikingly unevenly distributed across the globe, with frequencies ranging from nearly zero in parts of East Asia to roughly 29% in certain populations of western Europe and North Africa. The pattern does not follow a smooth gradient, and the reasons behind it remain one of the more puzzling questions in human population genetics. Understanding this map means grappling with ancient migrations, a dangerous pregnancy complication, and a paradox that has kept evolutionary biologists arguing for decades.
Where Rh-Negative Blood Is Most and Least Common
If you color-coded a world map by the frequency of Rh-negative individuals, the hotspot would sit squarely over western Europe. Britain has an Rh-negative rate of about 17%, and the United States sits around 15%. But within Europe, the numbers climb higher in certain pockets. The Basque people of northern Spain and southwestern France carry the highest documented frequency of the RHD gene deletion, at about 47% for the deletion allele itself, which translates to roughly 29% of the population testing Rh-negative by standard blood typing.1PubMed Central. Sequence diversity of the Rh blood group system in Basques Distinct populations in the High Atlas mountains of Morocco and at least one region of Saudi Arabia show similarly high rates, around 29%.2PubMed Central. High rhesus (Rh(D)) negative frequency and ethnic-group based ABO blood group distribution in Ethiopia
Move south and east, and the picture shifts dramatically. In sub-Saharan Africa, Rh-negative rates are generally low but not negligible: Nigeria reports about 6%, though Ethiopia shows rates closer to western European levels in some ethnic groups. Madagascar sits at roughly 1%. In South and Southeast Asia, Rh negativity ranges from under 1% to about 8% depending on the region of India, and drops below 1% in China, Indonesia, and Japan.2PubMed Central. High rhesus (Rh(D)) negative frequency and ethnic-group based ABO blood group distribution in Ethiopia Indigenous populations in the Americas and Australia had very low or absent Rh-negative frequencies before European contact, and the rates found today largely reflect post-colonial admixture.
Why the Basques Stand Out
The Basque people turn up in nearly every discussion of Rh-negative distribution, and for good reason. Their RHD deletion frequency of about 47% is the highest confirmed by molecular analysis in any well-studied population.1PubMed Central. Sequence diversity of the Rh blood group system in Basques The Basques are linguistically isolated: their language, Euskara, is unrelated to any other living language. They also show unusual frequencies in several other genetic markers beyond Rh, which has led to a long tradition of treating them as a kind of genetic time capsule from pre-Indo-European western Europe.
The high Rh-negative frequency among Basques is usually explained by a combination of genetic drift in a relatively small, long-isolated population and possible selection pressures that we still don’t fully understand. The High Atlas Berber populations with similarly elevated rates also tend to be geographically isolated mountain communities, which suggests that population bottlenecks and restricted gene flow can push the Rh-negative allele to unusually high levels. The Saudi Arabian finding is harder to explain through isolation alone and remains an active question.
The Evolutionary Paradox
Here is what makes the global distribution genuinely strange: being Rh-negative should, in theory, be selected against. When an Rh-negative woman carries an Rh-positive baby, her immune system can produce antibodies against the baby’s red blood cells. This condition, hemolytic disease of the fetus and newborn, can cause severe anemia, brain damage, or death in affected pregnancies.3PubMed Central. Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects Usually the first pregnancy is fine because the mother hasn’t been sensitized yet, but second and subsequent Rh-positive pregnancies carry increasing risk. Before modern medicine, this was a significant cause of infant death.
Given that cost, you would expect natural selection to have driven the Rh-negative allele to near-extinction. Instead, it sits at appreciable frequencies in European populations, with the RHD gene deletion reaching about 0.43 in some study samples.4PubMed Central. Evolutionary genetics of the human Rh blood group system Something has kept it around, and the leading explanation is a form of balancing selection in which people who carry one copy of the deletion and one functional copy enjoy some health advantage over people who are homozygous in either direction.
Heterozygote Advantage as the Leading Explanation
The concept is straightforward: if carrying one copy of the Rh-negative allele and one copy of the Rh-positive allele makes you healthier or more reproductively successful than people with two copies of either version, the negative allele never disappears from the population despite its reproductive cost when homozygous. An ecological regression study across multiple populations found evidence consistent with this idea, suggesting that Rh heterozygotes have higher resistance or tolerance to certain diseases.5PLOS ONE. Heterozygote Advantage Probably Maintains Rhesus Factor Blood Group Polymorphism: Ecological Regression Study
A preregistered study of over 2,500 people whose Rh genotype was estimated from family data put this more precisely. It confirmed that Rh-negative homozygotes had worse physical and mental health than Rh-positive individuals, but it also found something new: Rh-positive homozygotes appeared to suffer worse health than Rh-negative homozygotes, while Rh-positive heterozygotes enjoyed the best health of all three groups.6Journal of Evolutionary Biology. The role of balancing selection in maintaining human RhD blood group polymorphism: A preregistered cross‐sectional study That pattern is the classic signature of heterozygote advantage, the same mechanism that keeps the sickle-cell allele common in malaria zones. The researchers concluded this “strongly supports” the idea that balancing selection maintains the Rh polymorphism.
What specific diseases drive this advantage remains less clear. A separate study looking at broader health patterns found that Rh-negative individuals had higher rates of certain heart diseases, respiratory conditions, and autoimmune disorders like rheumatoid arthritis, but appeared more resistant to some viral infections and less resistant to bacterial ones.7PubMed Central. Worse Health Status and Higher Incidence of Health Disorders in Rhesus Negative Subjects The picture that emerges is not one of a simple “better or worse” blood type but of complex trade-offs that shift depending on the disease environment.
The Toxoplasma Connection
One of the more specific and provocative findings involves the parasite Toxoplasma gondii, which infects roughly a third of the world’s population. Research has consistently found that Rh status modifies how Toxoplasma infection affects the host. In studies of physical performance, Toxoplasma-infected Rh-negative subjects showed lower performance on weight-holding and grip-strength tests compared to uninfected Rh-negative people, while Toxoplasma-infected Rh-positive subjects actually performed slightly better than their uninfected peers.8PubMed Central. Lower performance of Toxoplasma-infected, Rh-negative subjects in the weight holding and hand-grip tests
A similar pattern showed up in cognitive testing. Toxoplasma-infected Rh-negative men showed different intelligence scores compared to uninfected men, with the differences being consistently larger in Rh-negative than in Rh-positive subjects.9PLOS ONE. Toxoplasmosis-Associated Difference in Intelligence and Personality in Men Depends on Their Rhesus Blood Group but Not ABO Blood Group The Rh protein on red blood cells may somehow interact with how the parasite affects the body, though the exact mechanism remains uncertain. If Rh-positive status protects against the worst effects of a globally common parasite, that could be one of the selective pressures keeping the positive allele dominant in most populations while heterozygotes get the best of both worlds.
Rh Blood Groups in Neanderthals and Denisovans
Ancient DNA has added an unexpected layer to the Rh story. Analysis of high-quality genome sequences from three Neanderthals and one Denisovan individual revealed that these archaic humans carried RHD and RHCE alleles associated with a high risk of hemolytic disease of the fetus and newborn.10PubMed Central. Blood groups of Neandertals and Denisova decrypted In other words, Rh incompatibility was a potential problem long before modern humans existed in their current form. The Neanderthal Rh variants were not identical to the common modern European deletion but represented a distinct haplotype encoding partial RhD antigens.11Scientific Reports. Rapid change in red cell blood group systems after the main Out of Africa of Homo sapiens
One particularly interesting finding connects a Neanderthal RHD allele to variants found today in Aboriginal Australian and Papuan populations, suggesting that a segment of archaic Rh-related DNA was introduced into non-Eurasian modern humans through interbreeding.10PubMed Central. Blood groups of Neandertals and Denisova decrypted This doesn’t mean that the common European Rh-negative deletion came from Neanderthals. Rather, it shows that the Rh system has been under evolutionary pressure and exchanging variants between hominin lineages for hundreds of thousands of years. The current global distribution reflects not just one event but overlapping histories of mutation, drift, selection, and archaic admixture.
How Anti-D Immunoprophylaxis Changed the Map’s Consequences
Before the 1960s, hemolytic disease of the newborn was a major cause of infant illness and death in populations with high Rh-negative frequencies. The development of anti-D immunoglobulin (commonly called the RhoGAM shot in the United States) transformed this picture. A Cochrane systematic review found that anti-D given within 72 hours of birth slashed the rate of maternal sensitization by roughly 96% at six months and substantially reduced sensitization in subsequent pregnancies, regardless of whether the mother and baby had compatible ABO blood types.12Cochrane Database of Systematic Reviews. Anti‐D administration after childbirth for preventing Rhesus alloimmunisation
A separate systematic review confirmed that postpartum anti-D reduced sensitization by about 39 to 70 per 1,000 women depending on ABO compatibility, and that when women were followed into their next Rh-positive pregnancy, about 130 fewer per 1,000 were sensitized compared to women who received no treatment.13PLOS ONE. Antenatal and postpartum prevention of Rh alloimmunization: A systematic review and GRADE analysis This prophylaxis is now routine in high-income countries. In places without reliable access to anti-D, hemolytic disease of the newborn remains a significant threat, and the practical consequences of the Rh-negative map are still felt acutely.
From an evolutionary standpoint, widespread anti-D use effectively removes the major selective penalty against the Rh-negative allele. Some researchers have speculated that this could allow Rh-negative frequencies to rise over time in populations where prophylaxis is universal, though given the slow pace of allele frequency change and the relatively recent introduction of the treatment, any measurable shift would take many generations.
Weak D and Variant Phenotypes Complicate the Map
The simple binary of “Rh-positive or Rh-negative” on a world map hides a layer of complexity. Not everyone who types as Rh-negative on a standard blood test is actually missing the RHD gene entirely. Some people carry mutated versions of RHD that produce a weakened or partial form of the D protein. These “weak D” and “partial D” variants behave differently in lab tests depending on the method used, and they matter for both blood transfusion safety and pregnancy management.
A study of over 33,000 ethnically diverse patients in the United States found that about 1% of those typing as D-negative actually carried mutated RHD alleles, including variants common in people of African descent like DAR and DVa-like alleles.14PubMed. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention In northeast China, a study of over 132,000 blood donors found that about 0.03% had a serologically weak D phenotype, with 17 distinct RHD mutation alleles identified, including two previously unknown ones.15PubMed Central. Molecular and computational analysis of 45 samples with a serologic weak D phenotype detected among 132,479 blood donors in northeast China In Thailand, molecular analysis of weak and partial D samples identified 36 variant alleles, with the most common one also found in South China and another recently reported from India.16Transfusion Medicine and Hemotherapy. Comprehensive Molecular Analysis of Serologically D-Negative and Weak/Partial D Phenotype in Thai Blood Donors
The geographic distribution of these variants follows its own pattern that doesn’t simply mirror overall Rh-negative frequency. African-descent populations carry a particularly diverse set of RHD variants, many of which can cause clinical problems during transfusion or pregnancy if misidentified. This means that a world map showing only “Rh-positive versus Rh-negative” misses a significant amount of medically relevant variation, especially in populations where overall Rh-negative rates appear low.
Rh-Null, the Rarest Blood of All
At the extreme end of the Rh spectrum sits Rh-null, sometimes called “golden blood” in popular accounts. People with the Rh-null phenotype lack all Rh antigens on their red blood cells, not just the D antigen that defines ordinary Rh-negative status. Fewer than 50 individuals have been identified worldwide. The phenotype arises either from homozygosity for a suppressor gene unrelated to the RH locus or from inheriting two silent alleles at the RH locus itself.17Best Practice & Research Clinical Haematology. RH blood group system and molecular basis of Rh-deficiency
Rh-null blood is universal within the Rh system, meaning it can theoretically be transfused to anyone without triggering an Rh-related reaction. But that universality is purely theoretical for most purposes because the supply essentially doesn’t exist. Rh-null individuals who need transfusions face enormous logistical challenges, often relying on internationally coordinated frozen blood banks.
The condition also comes with a medical cost. Rh proteins play a structural role in the red blood cell membrane, and without them, the cells are fragile. Rh-null individuals typically have a mild chronic hemolytic anemia with features resembling hereditary spherocytosis, including abnormal cell shapes and increased fragility when exposed to changes in salt concentration.18Blood. Hematological Observations on the Anemia Associated with Blood Type Rhnull An Iranian case report confirmed these features, documenting spherocytic hemolytic anemia and stomatocytosis in identified Rh-null individuals.19PubMed Central. First Report of Known Rare Rhnull Phenotype Individuals in Iran Unlike ordinary hereditary spherocytosis, which is dominant, Rh-null anemia follows a recessive inheritance pattern.18Blood. Hematological Observations on the Anemia Associated with Blood Type Rhnull
Myths and Misinformation Around Rh-Negative Blood
Search for “Rh-negative blood type” online and you will quickly encounter claims that it proves alien ancestry, royal bloodlines, or connections to lost civilizations like Atlantis. These ideas have no scientific basis whatsoever. The RHD deletion responsible for most Rh-negative blood is a well-characterized mutation in a gene on chromosome 1, and its molecular history is traceable through both modern and ancient DNA. The confusion seems to stem from the genuine scientific puzzle of why the allele persists at high frequency despite its reproductive cost, which some people interpret as evidence that it must have come from “somewhere else.” The answer is far more mundane: balancing selection, genetic drift in isolated populations, and complex trade-offs between disease susceptibility and resistance.
Another common myth holds that Rh-negative people have fundamentally different personalities or abilities. While some studies have found statistical associations between Rh status and certain health or performance measures, the effect sizes are small and the mechanisms uncertain. Being Rh-negative does not make you more intuitive, more psychic, or more likely to be abducted by aliens. It means your red blood cells lack a particular surface protein, which matters primarily during pregnancy and blood transfusion.
How Historical Discovery Shaped Modern Blood Banking
The Rh system was identified in 1940 by Karl Landsteiner and Alexander Wiener, building on Landsteiner’s earlier Nobel Prize-winning work identifying the ABO blood groups.20PubMed Central. Karl Landsteiner (1868-1943): A Versatile Blood Scientist The discovery came from experiments with rhesus monkey blood, which is how the system got its name, though the connection to rhesus monkeys turned out to be more complicated than originally thought, and the nomenclature has been a source of confusion ever since.
What the discovery immediately explained was why some blood transfusions failed even when the ABO types matched, and why some women lost second or third babies to a mysterious anemia. The identification of the Rh factor turned hemolytic disease of the newborn from an unexplained tragedy into a preventable condition, though it took another quarter century before anti-D prophylaxis became widely available. Today the Rh system is recognized as one of the most complex human blood group systems, with over 50 distinct antigens identified beyond the familiar D antigen. That complexity, invisible on any global distribution map, is part of what makes the system so difficult to study and so resistant to simple evolutionary explanations.